271 related articles for article (PubMed ID: 10766254)
1. Medicinal strategies in the treatment of obesity.
Bray GA; Tartaglia LA
Nature; 2000 Apr; 404(6778):672-7. PubMed ID: 10766254
[TBL] [Abstract][Full Text] [Related]
2. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of obesity: an update.
Schurgin S; Siegel RD
Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
[TBL] [Abstract][Full Text] [Related]
4. Medications for weight reduction.
Bray GA
Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
[TBL] [Abstract][Full Text] [Related]
5. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
Svendsen M; Helgeland M; Tonstad S
J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical approaches to the treatment of obesity.
Jandacek RJ; Woods SC
Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320
[TBL] [Abstract][Full Text] [Related]
7. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
8. [A practicing physician's view on obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
[TBL] [Abstract][Full Text] [Related]
9. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats.
Ortmann S; Kampe J; Gossel M; Bickel M; Geisen K; Jähne G; Lang HJ; Klaus S
Obes Res; 2004 Aug; 12(8):1290-7. PubMed ID: 15340112
[TBL] [Abstract][Full Text] [Related]
10. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
12. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
Fujioka K
Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.
Baptista T; de Baptista EA; Lalonde J; Plamondon J; Kin NM; Beaulieu S; Joober R; Richard D
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1305-11. PubMed ID: 15588757
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
15. Emerging pharmacological approaches to the treatment of obesity.
Wasan KM; Looije NA
J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats.
Romero MM; Esteve M; Alemany M
Int J Obes (Lond); 2006 Jul; 30(7):1149-56. PubMed ID: 16418752
[TBL] [Abstract][Full Text] [Related]
17. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
18. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
[TBL] [Abstract][Full Text] [Related]
19. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
20. An update on the pharmacological treatment of obesity.
Schnee DM; Zaiken K; McCloskey WW
Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
